Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial.
Arabi YM, Asiri AY, Assiri AM, Aziz Jokhdar HA, Alothman A, Balkhy HH, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Memish ZA, Ghazal S, Al Faraj S, Al-Hameed F, AlSaedi A, Mandourah Y, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, Almotairi A, Al Bshabshe A, Kharaba A, Jose J, Al Harthy A, Al Sulaiman M, Mady A, Fowler RA, Hayden FG, Al-Dawood A, Abdelzaher M, Bajhmom W, Hussein MA; and the Saudi Critical Care Trials group. Arabi YM, et al. Among authors: kojan s. Trials. 2020 Jan 3;21(1):8. doi: 10.1186/s13063-019-3846-x. Trials. 2020. PMID: 31900204 Free PMC article.
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.
Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Assiri AM, Al-Hameed F, AlSaedi A, Mandourah Y, Almekhlafi GA, Sherbeeni NM, Elzein FE, Memon J, Taha Y, Almotairi A, Maghrabi KA, Qushmaq I, Al Bshabshe A, Kharaba A, Shalhoub S, Jose J, Fowler RA, Hayden FG, Hussein MA; And the MIRACLE trial group. Arabi YM, et al. Among authors: kojan s. Trials. 2018 Jan 30;19(1):81. doi: 10.1186/s13063-017-2427-0. Trials. 2018. PMID: 29382391 Free PMC article.
Exploring the outcome of multiple sclerosis among Saudi adult patients. A single-centered cross-sectional study at King Abdulaziz Medical City in Riyadh, Saudi Arabia.
Alanazi AM, Al-Rashoud JR, Aljahani JM, Alotaibi AF, Althubaiti AM, Kojan SM, Aljumah MA, Abulaban AA. Alanazi AM, et al. Among authors: kojan sm. Neurosciences (Riyadh). 2019 Jul;24(3):168-175. doi: 10.17712/nsj.2019.3.20180034. Neurosciences (Riyadh). 2019. PMID: 31380815 Free PMC article.
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a.
Al Jumah M, Kojan S, Alroughani R, Cupler E, Bohlega S, Daif A, Al Mujalli M, Al Harbi T, El Tamawy M, Ashour S, Mhiri C, Gouider R, Jawhary A, El Boghdady A, Hussein M. Al Jumah M, et al. Among authors: kojan s. Mult Scler Int. 2021 Mar 2;2021:6681431. doi: 10.1155/2021/6681431. eCollection 2021. Mult Scler Int. 2021. PMID: 33747564 Free PMC article.
34 results